{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fa16z.simplecast.com%2Fepisodes%2Fthe-shift-in-global-drug-development-Ch15YbK8","width":444,"version":"1.0","type":"rich","title":"The Shift in Global Drug Development","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/0d97354a-306b-45f5-bf26-a8d81eef47ec/ed2664df-9371-438e-8baf-dd2ee0fdde87/thea16zshow-podcastcoverart-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/f506f927-9c0e-4e5d-8005-df1f5036948f\" height=\"200\" width=\"100%\" title=\"The Shift in Global Drug Development\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the regulatory reforms that accelerated China’s progress, the surge in novel drug development, and what the US would need to change to stay competitive in biomedical innovation."}